Y - Alleghany Profile, Stock Quotes, Financial Analysis, Charts, Fundamentals

Alleghany Corp (Y)

Other Ticker:

Sector • Financial Industry • Property & Casualty Insurance

Industry • Property & Casualty Insurance

Sector • Financial

Price: $765.6700 $15.00

1.998%

Day's High:	$767.01	Week Perf:	1.61 %
Day's Low:	$ 756.24	30 Day Perf:	10.47 %
Volume (M):	121	52 Wk High:	$ 767.01
Volume (M$):	$ 92,340	52 Wk Avg:	$645.83
Open:	$756.24	52 Wk Low:	$574.42

Y Charts & Quotes

Y Charts & Quotes

Description of Company's Segments

Market Capitalization (Millions $)	11,057
Shares Outstanding (Millions)	14
Employees	3,135
Revenues (TTM) (Millions $)	7,984
Net Income (TTM) (Millions $)	338
Cash Flow (TTM) (Millions $)	202
Capital Exp. (TTM) (Millions $)	34

Alleghany Corp
We are a Delaware corporation which owns and manages certain operating subsidiaries and investments, anchored by a core position in property and casualty reinsurance and insurance. We were initially incorporated in 1929, were subsequently incorporated in 1984 under the laws of the State of Delaware and, in December 1986, we succeeded to the business of our parent company, Alleghany Corporation. Through our wholly-owned subsidiary AIHL and its subsidiaries, we are engaged in the property and casualty insurance business. AIHL’s insurance operations are principally conducted by its subsidiaries RSUI, CapSpecialty and PacificComp. CapSpecialty has been a subsidiary of AIHL since January 2002, RSUI has been a subsidiary of AIHL since July 2003 and PacificComp has been a subsidiary of AIHL since July 2007. AIHL Re, a captive reinsurance company which provides reinsurance to Alleghany’s insurance operating subsidiaries and affiliates, has been a wholly-owned subsidiary of Alleghany since its formation in May 2006. Our reinsurance operations commenced on March 6, 2012 when we consummated a merger with TransRe, and TransRe became one of our wholly-owned subsidiaries. Our public equity investments, including those held by TransRe’s and AIHL’s operating subsidiaries, are managed primarily through our wholly-owned subsidiary Roundwood.

Y is expected to report next financial results on November 04, 2019.

Alleghany's Segments

• View Complete Report

	Company Estimates
	• Revenue Outlook Alleghany does not provide revenue guidance. • Earnings Outlook Alleghany Corp does not provide earnings estimates.

Geographic Revenue Dispersion

News

Parkway Acquisition Corp.

Surge in Revenues and Earnings

Parkway Acquisition Corp announced strong results in the second quarter, where Revenues rose by 23.81 % to $7.90 millions and profits soared by 40 % to $0.28 per share, year on year.

Cell Source, Inc.

Deficit Bigger Than a Year Ago but Revenues Unchanged

In the second quarter Cell Source, Inc losses widen of $-0.04 per share compare to $-0.02 a year ago and improved from $-0.06 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Data I

Data I announced second quarter operating income of $0.075 millions

In the second quarter Data I eps remained unchanged of $0.02 per share compare to $0.02 a year ago and eps dropped by -73.74 % from $0.08 per share from the previous quarter.

Sales crumbled by -23.53 % to $5.83 millions from $7.63 millions in the same quarter a year ago and sequentially Sales fell by -25.76 % from $7.86 millions.

American Bio Medica Corp

American Bio Medica Corp announced second quarter operating loss of $-0.155 millions

In the second quarter American Bio Medica Corp reached break-even of $0.00 per share compare to $0.00 a year ago and from $-0.01 per share from the previous quarter.

Sales declined in double digits by -10.38 % to $0.96 millions from $1.07 millions in the same quarter a year ago and sequentially Sales increased by 3.79 % from $0.92 millions.

Image Chain Group Limited, Inc.

Sales and Earnings Unchanged

In the second quarter Image Chain Group Limited, Inc reached break-even of $0.00 per share compare to $0.00 a year ago and from $-0.01 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.06 millions in the same quarter a year ago and sequentially from $0.00 millions.

Y's Valuation	Current
Price to Earnings PE Ratio (TTM)	34.82
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	1.38
Price to Sales (Expected)	-
Price to Book	1.27
PEG (TTM)	2.51

Y's Financial Strength	Current
Quick Ratio	1.6
Working Capital Ratio	1.74
Leverage Ratio (MRQ)	2.03
Total Debt to Equity	0.2
Interest Coverage (TTM)	6.35
Debt Coverage (TTM)	0.37

Per Share	Current
Earnings (TTM)	21.99 $
Revenues (TTM)	552.91 $
Cash Flow (TTM)	13.96 $
Cash	1315.26 $
Book Value	601.48 $
Dividend (TTM)	0 $

Y's Efficiency	Current
Revenue per Employee (TTM)	2,546,881
Net Income per Employee (TTM)	107,752
Receivable Turnover Ratio (TTM)	-
Inventory Turnover Ratio (TTM)	-
Asset Turnover Ratio (TTM)	0.31

Y's Profitability Ratio	Current
Gross Margin	64.72 %
Operating Margin	43.9 %
Net Margin	13.5 %
Net Cash Flow Margin	2.07 %
Effective Tax Rate (TTM)	13.77 %

Management Effectiveness	Current
Return On Assets (TTM)	1.32 %
Return On Investment (TTM)	2.46 %
Return On Equity (TTM)	4.07 %
Dividend Yield	-
Payout Ratio (TTM)	-

Y's Valuation
Price to Earnings PE Ratio (TTM)	34.82
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	1.38
Price to Sales (Expected)	-
Price to Book	1.27
PEG (TTM)	2.51

Y's Financial Strength
Quick Ratio	1.6
Working Capital Ratio	1.74
Leverage Ratio (MRQ)	2.03
Total Debt to Equity	0.2
Interest Coverage (TTM)	6.35
Debt Coverage (TTM)	0.37

Per Share
Earnings (TTM)	21.99 $
Revenues (TTM)	552.91 $
Cash Flow (TTM)	13.96 $
Cash	1315.26 $
Book Value	601.48 $
Dividend (TTM)	0 $

• View Valuation Comparisons

• View Growth Rates Comparisons

Y's Efficiency
Revenue per Employee (TTM)	2,546,881
Net Income per Employee (TTM)	107,752
Receivable Turnover Ratio (TTM)	-
Inventory Turnover Ratio (TTM)	-
Asset Turnover Ratio (TTM)	0.31

Y's Profitability Ratio
Gross Margin	64.72 %
Operating Margin	43.9 %
Net Margin	13.5 %
Net Cash Flow Margin	2.07 %
Effective Tax Rate (TTM)	13.77 %

Management Effectiveness
Return On Assets (TTM)	1.32 %
Return On Investment (TTM)	2.46 %
Return On Equity (TTM)	4.07 %
Dividend Yield	-
Payout Ratio (TTM)	-

• View Efficiency Comparisons

• View Profitability Comparisons

• View Management Effectiveness

Customers Net Income grew by	Y's customers Net margin grew to
34.97 %	9.08 %

• Customers Performance

• Customers Expend.

• Customers Efficiency

• List of Customers

Reports on Competition

List of Competitors

Competitors by Segment

Segment Growth

Growth Rates

Suppliers At a Glance

List of Suppliers

Suppliers Performance

Major Competitors

Stock performance

5 Days	Decrease / Increase

AIG	-0.49%
PGR	-1.4%
MKL		0.69%
L	-1.84%
CB	-0.83%
ALL		1.11%
• View Complete Report

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar RUSHB's Profile Stock Price RUSHB's Financials Business Description Fundamentals Charts & Quotes RUSHB's News Suppliers RUSHB's Competitors Customers & Markets Economic Indicators RUSHB's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

Y Company Profile

Surge in Revenues and Earnings

Deficit Bigger Than a Year Ago but Revenues Unchanged

Data I announced second quarter operating income of $0.075 millions

American Bio Medica Corp announced second quarter operating loss of $-0.155 millions

Sales and Earnings Unchanged